<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[China-Biotics Inc. | Company News & Executive Profiles - CHBT | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/china-biotics+inc..html?i=6]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for China-Biotics Inc.]]></description>
	<s:counts start="0" returned="5" found="5" />
	<language>en-us</language>
	<item>
		<title><![CDATA[China-Biotics: An Undervalued Stock with a Growth Catalyst]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F158305-china-biotics-an-undervalued-stock-with-a-growth-catalyst%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[China-Biotics Inc. CHBT may not be in the most glamorous business dealing with bacteria, but its stock appears quite appetizing for investors. The company is one of the few domestic producers of probiotics in a baby formula market that primarily relies on imports, while it is also rapidly expanding its...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 26 Aug 2009 12:27:52 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/simon+monger.html"><![CDATA[Simon Monger]]></category>
		<category domain="http://resources.bnet.com/topic/china-biotics+inc..html"><![CDATA[China-Biotics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CHBT</category>
		<category domain="tickers">CHBT</category>
	</item>
	<item>
		<title><![CDATA[China-Biotics Reports Gains in FY2009]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F149104-china-biotics-reports-gains-in-fy2009%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  China-Biotics, Inc. (NSDQ: CHBT) reported positive financial results for its 2009 fiscal year, which ended in March. Sales rose 28% to $54.2 million, and non-GAAP net income climbed 19% to $16.9 million, a very healthy margin of 31%. Revenues were in line with analysts&#8217; expectations, but...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 15 Jul 2009 11:37:49 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/china-biotics+inc..html"><![CDATA[China-Biotics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CHBT</category>
		<category domain="tickers">CHBT</category>
	</item>
	<item>
		<title><![CDATA[China-Biotics's Q3 Shows Improvement]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F120844-china-biotics-s-q3-shows-improvement%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  China-Biotics, Inc. CHBT released its Q3 financial report, showing that, compared to last&#8217;s years Q3, revenues climbed 33% to $15.8 million while net income rose 40% to $5.7 million. The company, which makes probiotic products, attributed its improved performance to a combination of new products and...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 17 Feb 2009 12:58:56 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/china-biotics+inc..html"><![CDATA[China-Biotics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CHBT</category>
		<category domain="tickers">CHBT</category>
	</item>
	<item>
		<title><![CDATA[Four Probiotic Products Added to China-Biotics' Lineup]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F115639-four-probiotic-products-added-to-china-biotics-lineup%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  China-Biotics, Inc. (NSDQ: CHBT) received manufacturing certificates from the SFDA for several additions to its probiotic line of products. These include Synbiotics Capsules, Probiotics Gegen Capsules, Probiotics Tremella Polysaccharide Capsules and Probiotics Chewable Tablets. Probiotics are live microbial food supplements designed to promote intestinal microbial balance....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 21 Jan 2009 04:51:32 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/china-biotics+inc..html"><![CDATA[China-Biotics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CHBT</category>
		<category domain="tickers">CHBT</category>
	</item>
	<item>
		<title><![CDATA[China-Biotics Delays Plant Construction on Regulatory Conflicts]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F114839-china-biotics-delays-plant-construction-on-regulatory-conflicts%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  China-Biotics, Inc. CHBT, a probiotics company, reported that construction of its new manufacturing plant in Shanghai has been delayed. The company blamed the delay on regulatory conflicts. Two agencies have jurisdiction over the facility, the SFDA and the Shanghai Municipal Bureau of Quality and Technical Supervision,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 14 Jan 2009 10:39:17 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/china-biotics+inc..html"><![CDATA[China-Biotics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CHBT</category>
		<category domain="tickers">CHBT</category>
	</item>
</channel>
</rss>
